305 related articles for article (PubMed ID: 28826298)
1. Evaluation of mesoporous silica particles as drug carriers in hydrogels.
Lunter DJ
Pharm Dev Technol; 2018 Oct; 23(8):826-831. PubMed ID: 28826298
[TBL] [Abstract][Full Text] [Related]
2. Delivery of curcumin by a pH-responsive chitosan mesoporous silica nanoparticles for cancer treatment.
Ahmadi Nasab N; Hassani Kumleh H; Beygzadeh M; Teimourian S; Kazemzad M
Artif Cells Nanomed Biotechnol; 2018 Feb; 46(1):75-81. PubMed ID: 28278578
[TBL] [Abstract][Full Text] [Related]
3. The investigation of MCM-48-type and MCM-41-type mesoporous silica as oral solid dispersion carriers for water insoluble cilostazol.
Wang Y; Sun L; Jiang T; Zhang J; Zhang C; Sun C; Deng Y; Sun J; Wang S
Drug Dev Ind Pharm; 2014 Jun; 40(6):819-28. PubMed ID: 23594300
[TBL] [Abstract][Full Text] [Related]
4. Development of solid SEDDS, VII: Effect of pore size of silica on drug release from adsorbed self-emulsifying lipid-based formulations.
Gumaste SG; Serajuddin ATM
Eur J Pharm Sci; 2017 Dec; 110():134-147. PubMed ID: 28506870
[TBL] [Abstract][Full Text] [Related]
5. Mesoporous silica formulation strategies for drug dissolution enhancement: a review.
McCarthy CA; Ahern RJ; Dontireddy R; Ryan KB; Crean AM
Expert Opin Drug Deliv; 2016; 13(1):93-108. PubMed ID: 26549623
[TBL] [Abstract][Full Text] [Related]
6. Electrosprayed mesoporous particles for improved aqueous solubility of a poorly water soluble anticancer agent: in vitro and ex vivo evaluation.
Sayed E; Karavasili C; Ruparelia K; Haj-Ahmad R; Charalambopoulou G; Steriotis T; Giasafaki D; Cox P; Singh N; Giassafaki LN; Mpenekou A; Markopoulou CK; Vizirianakis IS; Chang MW; Fatouros DG; Ahmad Z
J Control Release; 2018 May; 278():142-155. PubMed ID: 29605567
[TBL] [Abstract][Full Text] [Related]
7. Preparation, Characterization, and Evaluation of the Anticancer Effect of Mesoporous Silica Nanoparticles Containing Rutin and Curcumin.
Dizaj SM; Kouhsoltani M; Pourreza K; Sharifi S; Abdolahinia ED
Pharm Nanotechnol; 2024; 12(3):269-275. PubMed ID: 37594097
[TBL] [Abstract][Full Text] [Related]
8. Development of New Bexarotene-loaded Mesoporous Silica Systems for Topical Pharmaceutical Formulations.
Vasile A; Ignat M; Zaltariov MF; Sacarescu L; Stoleriu I; Draganescu D; Dumitras M; Ochiuz L
Acta Chim Slov; 2018 Mar; 65(1):97-107. PubMed ID: 29562115
[TBL] [Abstract][Full Text] [Related]
9. Physicochemical stability of high indomethacin payload ordered mesoporous silica MCM-41 and SBA-15 microparticles.
Limnell T; Heikkilä T; Santos HA; Sistonen S; Hellstén S; Laaksonen T; Peltonen L; Kumar N; Murzin DY; Louhi-Kultanen M; Salonen J; Hirvonen J; Lehto VP
Int J Pharm; 2011 Sep; 416(1):242-51. PubMed ID: 21763766
[TBL] [Abstract][Full Text] [Related]
10. Comparison of mesoporous silicon and non-ordered mesoporous silica materials as drug carriers for itraconazole.
Kinnari P; Mäkilä E; Heikkilä T; Salonen J; Hirvonen J; Santos HA
Int J Pharm; 2011 Jul; 414(1-2):148-56. PubMed ID: 21601623
[TBL] [Abstract][Full Text] [Related]
11. Enhanced dissolution and oral bioavailability of nifedipine by spontaneous emulsifying powders: effect of solid carriers and dietary state.
Weerapol Y; Limmatvapirat S; Jansakul C; Takeuchi H; Sriamornsak P
Eur J Pharm Biopharm; 2015 Apr; 91():25-34. PubMed ID: 25615879
[TBL] [Abstract][Full Text] [Related]
12. Bionanocomposites based on mesoporous silica and alginate for enhanced drug delivery.
de Lima HHC; Kupfer VL; Moisés MP; Guilherme MR; de C Rinaldi J; Felisbino SL; Rubira AF; Rinaldi AW
Carbohydr Polym; 2018 Sep; 196():126-134. PubMed ID: 29891279
[TBL] [Abstract][Full Text] [Related]
13. [Preparation and anti-cancer activity in vitro of curcumin loaded mesoporous silica nanoparticle].
He LL; Gu J
Zhongguo Zhong Yao Za Zhi; 2015 Nov; 40(21):4189-93. PubMed ID: 27071254
[TBL] [Abstract][Full Text] [Related]
14. Curcumin-loaded guanidine functionalized PEGylated I3ad mesoporous silica nanoparticles KIT-6: practical strategy for the breast cancer therapy.
Ma'mani L; Nikzad S; Kheiri-Manjili H; Al-Musawi S; Saeedi M; Askarlou S; Foroumadi A; Shafiee A
Eur J Med Chem; 2014 Aug; 83():646-54. PubMed ID: 25014638
[TBL] [Abstract][Full Text] [Related]
15. Phytochemical-loaded mesoporous silica nanoparticles for nose-to-brain olfactory drug delivery.
Lungare S; Hallam K; Badhan RK
Int J Pharm; 2016 Nov; 513(1-2):280-293. PubMed ID: 27633279
[TBL] [Abstract][Full Text] [Related]
16. Drug delivery formulations of ordered and nonordered mesoporous silica: comparison of three drug loading methods.
Limnell T; Santos HA; Mäkilä E; Heikkilä T; Salonen J; Murzin DY; Kumar N; Laaksonen T; Peltonen L; Hirvonen J
J Pharm Sci; 2011 Aug; 100(8):3294-3306. PubMed ID: 21520084
[TBL] [Abstract][Full Text] [Related]
17. Chemoresponsive smart mesoporous silica systems - An emerging paradigm for cancer therapy.
Murugan B; Krishnan UM
Int J Pharm; 2018 Dec; 553(1-2):310-326. PubMed ID: 30316004
[TBL] [Abstract][Full Text] [Related]
18. Curcumin-loaded silica-based mesoporous materials: Synthesis, characterization and cytotoxic properties against cancer cells.
Bollu VS; Barui AK; Mondal SK; Prashar S; Fajardo M; Briones D; Rodríguez-Diéguez A; Patra CR; Gómez-Ruiz S
Mater Sci Eng C Mater Biol Appl; 2016 Jun; 63():393-410. PubMed ID: 27040234
[TBL] [Abstract][Full Text] [Related]
19. Preparation of mesoporous silica microparticles by sol-gel/emulsion route for protein release.
Vlasenkova MI; Dolinina ES; Parfenyuk EV
Pharm Dev Technol; 2019 Feb; 24(2):243-252. PubMed ID: 29583055
[TBL] [Abstract][Full Text] [Related]
20. Core-shell microcapsules of solid lipid nanoparticles and mesoporous silica for enhanced oral delivery of curcumin.
Kim S; Diab R; Joubert O; Canilho N; Pasc A
Colloids Surf B Biointerfaces; 2016 Apr; 140():161-168. PubMed ID: 26752213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]